Colorectal Cancer - Medical Oncology Clinical Trials Resources
Listed below are the Colorectal Cancer - Medical Oncology Clinical Trials offered at the Kaiser Permanente Santa Clara Medical Center.
| |
|
| Title: |
A PHASE III TRIAL OF IRINOTECAN / 5-FU / LEUCOVORIN OR OXALIPLATIN / 5-FU/LEUCOVORIN WITH BEVACIZUMAB, OR CETUXIMAB (C225), OR WITH THE COMBINATION OR BEVACIZUMAB AND CETUXIMAB FOR PATIENTS WITH UNTREATED METASTATIC ADENOCARCINOMA OF THE COLON OR RECTUM |
| Phase: |
III |
| Protocol Number: |
CALGB-C80405 |
| Sponsors and Collaborators: |
CTSU (Cancer Trial Support Unit) |
| Weblink: |
Link to Clinical Trial |
| |
|
| Title: |
A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer |
| Phase: |
III |
| Protocol Number: |
C80702 |
| Sponsors and Collaborators: |
CTSU (Cancer Trial Support Unit) |
| |
|
| Title: |
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy |
| Phase: |
III |
| Protocol Number: |
N08CB |
| Sponsors and Collaborators: |
National Surgical Adjuvant Breast and Bowel Project (NSABP)
Bristol-Myers Squibb |
| Weblink: |
Link to Clinical Trial |
| |
|
| Title: |
A PHASE II STUDY TO DETERMINE THE SURGICAL CONVERSION RATE IN PATIENTS RECEIVING NEOADJUVANT MFOLFOX7 + CETUXIMAB FOR UNRESECTABLE WILD-TYPE K-RAS COLORECTAL CANCER WITH METASTASES CONFINED TO THE LIVER |
| Phase: |
II |
| Protocol Number: |
NSABP FC-6 |
| Sponsors and Collaborators: |
National Surgical Adjuvant Breast and Bowel Project (NSABP)
Bristol-Myers Squibb |
| Weblink: |
Link to Clinical Trial |
| |
|
| Title: |
STATIN POLYP PREVENTION TRIAL IN PATIENTS WITH RESECTED COLON CANCER |
| Phase: |
III |
| Protocol Number: |
NSABP-P-5 |
| Sponsors and Collaborators: |
National Surgical Adjuvant Breast and Bowel Project (NSABP)
National Cancer Institute (NCI) |
| Weblink: |
Link to Clinical Trial |
ONGOING STUDIES ONLY CLOSED FOR NEW PARTICIPANTS |
| |
|
| Title: |
5-FLUOROURACIL, LEUCOVORIN, AND OXALIPLATIN (MFOLFOX6) CHEMOTHERAPY PLUS BEVACIZUMAB FOR PATIENTS WITH UNRESECTABLE STAGE IV COLON CANCER AND A SYNCHRONOUS ASYMPTOMATIC PRIMARY TUMOR |
| Phase: |
II |
| Modality: |
Chemotherapy |
| Sponsors and Collaborators: |
National Surgical Adjuvant Breast and Bowel Project (NSABP) |
| Protocol Number: |
C-10 |
| Weblink: |
Link to Clinical Trial |
| |
|
| Title: |
POSTOPERATIVE OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN VS OXALIPLATIN, 5-FLUOROURACIL, LEUCOVORIN AND BEVACIZUMAB FOR PATIENTS WITH STAGE II OR III RECTAL CANCER RECEIVING PRE-OPERATIVE CHEMORADIATION |
| Phase: |
III |
| Modality: |
Chemotherapy |
| Sponsors and Collaborators: |
- Eastern Cooperative Oncology Group
- National Cancer Institute (NCI)
- National Surgical Adjuvant Breast and Bowel Project (NSABP)
- North Central Cancer Treatment Group
- National Cancer Institute of Canada
|
| Protocol Number: |
E5204 |
| Weblink: |
Link to Clinical Trial |
| |
|
| Title: |
A CLINICAL TRIAL COMPARING PREOPERATIVE RADIATION THERAPY AND CAPECITABINE WITH OR WITHOUT OXALIPLATIN WITH PREOPERATIVE RADIATION THERAPY AND CONTINUOUS INTRAVENOUS INFUSION OF 5-FLUOROURACIL WITH OR WITHOUT OXALIPLATIN IN THE TREATMENT OF PATIENTS WITH OPERABLE CARCINOMA OF THE RECTUM |
| Phase: |
III |
| Protocol Number: |
R-04 |
| Sponsors and Collaborators: |
NSABP (National Surgical Adjuvant Breast and Bowel Project) |
| Weblink: |
Link to Clinical Trial |
| |
|
| Title: |
A MULTINATIONAL, RANDOMIZED, DOUBLE-BLIND STUDY, COMPARING THE EFFICACY OF AFLIBERCEPT ONCE EVERY 2 WEEKS VERSUS PLACEBO IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC) TREATED WITH IRINOTECAN / 5-FU COMBINATION (FOLFIRI) AFTER FAILURE OF AN OXALIPLATIN BASED REGIMEN |
| Phase: |
III |
| Protocol Number: |
EFC 10262 |
| Sponsors and Collaborators: |
Sanofi-aventis |
| Weblink: |
Link to Clinical Trial |
| |
|
| Title: |
A RANDOMIZED PHASE II CLINICAL TRIAL INVESTIGATING IRINOTECAN PLUS CETUXIMAB WITH OR WITHOUT ANTI-INSULIN-LIKE GROWTH FACTOR-I RECEPTOR MONOCLONAL ANTIBODY (IMC-A12) FOR THE TREATMENT OF PATIENTS WITH METASTATIC K-RAS WILD TYPE CARCINOMA OF THE COLON OR RECTUM THAT HAS PROGRESSED ON OXALIPLATIN AND BEVACIZUMAB GIVEN AS FIRST-LINE THERAPY |
| Phase: |
II |
| Protocol Number: |
FC-04 |
| Sponsors and Collaborators: |
NSABP (National Surgical Adjuvant Breast and Bowel Project ) |
| Weblink: |
Link to Clinical Trial |
